Top Markets
Coin of the day
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.

BioDelivery Sciences International, Inc.

BDSI
Classement en actions #16145
BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical... BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical firm dedicated to the advancement and commercialization of therapeutic products designed for long-term health conditions, serving markets both within the United States and internationally. The company's product offerings leverage its proprietary BioErodible MucoAdhesive drug delivery system—a slender, dissolving polymer film intended for application to the inner cheek—in addition to other drug administration methodologies. Its portfolio includes several key products: BELBUCA, a buprenorphine buccal film, is utilized for the ongoing management of persistent pain. Symproic functions as a peripherally acting mu-opioid receptor antagonist, specifically addressing opioid-induced constipation in adult patients suffering from chronic non-cancer pain. This also covers individuals whose chronic pain is a result of prior cancer or its treatment, provided they do not require frequent increases in opioid dosage. ELYXYB, an oral solution containing celecoxib, provides treatment for adult migraines, irrespective of the presence of an aura. ONSOLIS, a soluble fentanyl film administered buccally, is intended for the management of sudden, severe "breakthrough" pain experienced by cancer patients. Founded in 1997, BioDelivery Sciences International, Inc. is headquartered in Raleigh, North Carolina. As of March 18, 2022, the company operates as a subsidiary of Collegium Pharmaceutical, Inc.
Prix de l'action
$5.59
Dernière synchronisation: 2022-03-31
Capitalisation boursière
$310.83M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange BioDelivery Sciences International, Inc. (BDSI)

Catégorie

Le prix BDSI avec la capitalisation boursière de B
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
BDSI
$5.59
Capitalisation boursière de BioDelivery Sciences International, Inc.(BDSI)
Capitalisation boursière: $310.83M
En September 2026, BioDelivery Sciences International, Inc. a une capitalisation boursière de $310.83M. Cela fait de BioDelivery Sciences International, Inc. la 16145th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de BioDelivery Sciences International, Inc. du 2002 au 2026
BDSI par rapport au top 5 des plus populaires stocks
Prix pour BDSI L’actif B La capitalisation boursière de B Résultats
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
$94,589.29 $310.83M
$5.260T +1,692,016.05%
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
$85,937.53 $310.83M
$4.779T +1,537,244.07%
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
$72,237.43 $310.83M
$4.017T +1,292,161.67%
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
$66,888.39 $310.83M
$3.719T +1,196,472.32%
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
$49,172.81 $310.83M
$2.734T +879,556.70%